User Visitor Login
English only
EPFL > FSV > BBP > Channelpedia
Ion channels
Logged in as a Visitor.

All references automaticaly matched for SK4

169. Pubmed Vaidyanathan R. et al. IK1-enhanced human-induced pluripotent stem cell-derived cardiomyocytes: an improved cardiomyocyte model to investigate inherited arrhythmia syndromes. Am. J. Physiol. Heart Circ. Physiol., 2016 Jun 1 , 310 (H1611-21).
168. Pubmed Olamendi-Portugal T. et al. Isolation, chemical and functional characterization of several new K(+)-channel blocking peptides from the venom of the scorpion Centruroides tecomanus. Toxicon, 2016 Jun 1 , 115 (1-12).
167. Pubmed van der Heyden M. et al. Pharmacological exploration of the resting membrane potential reserve: Impact on atrial fibrillation. Eur. J. Pharmacol., 2016 Jan 15 , 771 (56-64).
166. Pubmed Yin M. et al. Activation of K(+) channel by 1-EBIO rescues the head and neck squamous cell carcinoma cells from Ca(2+) ionophore-induced cell death. Korean J. Physiol. Pharmacol., 2016 Jan , 20 (25-33).
165. Pubmed Pethő Z. et al. The anti-proliferative effect of cation channel blockers in T lymphocytes depends on the strength of mitogenic stimulation. Immunol. Lett., 2016 Feb 6 , 171 (60-69).
164. Pubmed Raychaudhuri S. et al. KCa3.1(-/-) Mice Do Not Develop CIA: Regulatory Role for KCa3.1 in Autoimmune Arthritis. J. Cell. Physiol., 2016 Feb 22 , ().
163. Pubmed Choi J. et al. Role of protein kinase A and class II phosphatidylinositol 3-kinase C2β in the downregulation of KCa3.1 channel synthesis and membrane surface expression by lyso-globotriaosylceramide. Biochem. Biophys. Res. Commun., 2016 Feb 19 , 470 (907-12).
162. Pubmed Mattheij N. et al. Survival protein anoctamin-6 controls multiple platelet responses including phospholipid scrambling, swelling, and protein cleavage. FASEB J., 2016 Feb , 30 (727-37).
161. Pubmed D'Alessandro G. et al. KCa3.1 channel inhibition sensitizes malignant gliomas to temozolomide treatment. Oncotarget, 2016 Apr 16 , ().
160. Pubmed Ohya S. et al. Downregulation of the Ca(2+)-activated K(+) channel KC a3.1 by histone deacetylase inhibition in human breast cancer cells. Pharmacol Res Perspect, 2016 Apr , 4 (e00228).
159. Pubmed Ye F. et al. The Scorpion Toxin Analogue BmKTX-D33H as a Potential Kv1.3 Channel-Selective Immunomodulator for Autoimmune Diseases. Toxins (Basel), 2016 , 8 ().
158. Pubmed Siddiqui T. et al. Complex molecular and functional outcomes of single versus sequential cytokine stimulation of rat microglia. J Neuroinflammation, 2016 , 13 (66).
157. Pubmed Ohya S. et al. Physiological Role of K(+) Channels in the Regulation of T Cell Function. Yakugaku Zasshi, 2016 , 136 (479-83).
156. Pubmed Cubeddu L. et al. Drug-induced Inhibition and Trafficking Disruption of ion Channels: Pathogenesis of QT Abnormalities and Drug-induced Fatal Arrhythmias. Curr Cardiol Rev, 2016 , 12 (141-54).
155. Pubmed Williams G. et al. A web portal for in-silico action potential predictions. J Pharmacol Toxicol Methods, 2015 Sep-Oct , 75 (10-6).
154. Pubmed Goedicke-Fritz S. et al. Evidence for functional and dynamic microcompartmentation of Cav-1/TRPV4/K(Ca) in caveolae of endothelial cells. Eur. J. Cell Biol., 2015 Jul-Sep , 94 (391-400).
153. Pubmed Bhuyan R. et al. Molecular dynamics of Kv1.3 ion channel and structural basis of its inhibition by scorpion toxin-OSK1 derivatives. Biophys. Chem., 2015 Aug-Sep , 203-204 (1-11).
152. Pubmed Yan Z. et al. Na+-induced Ca2+ influx through reverse mode of Na+-Ca2+ exchanger in mouse ventricular cardiomyocyte. Oncotarget, 2015 Sep 15 , 6 (23272-80).
151. Pubmed Bulk E. et al. Epigenetic dysregulation of KCa 3.1 channels induces poor prognosis in lung cancer. Int. J. Cancer, 2015 Sep 15 , 137 (1306-17).
150. Pubmed Glogowska E. et al. Mutations in the Gardos channel (KCNN4) are associated with hereditary xerocytosis. Blood, 2015 Sep 10 , 126 (1281-4).
149. Pubmed Rapetti-Mauss R. et al. A mutation in the Gardos channel is associated with hereditary xerocytosis. Blood, 2015 Sep 10 , 126 (1273-80).
148. Pubmed Zhang S. et al. [Effect of Kv1.3 and KCa3.1 potassium ion channels on the proliferation and migration of monocytes/macrophages]. Sheng Li Xue Bao, 2015 Oct 25 , 67 (505-12).
147. Pubmed Andolfo I. et al. Novel Gardos channel mutations linked to dehydrated hereditary stomatocytosis (xerocytosis). Am. J. Hematol., 2015 Oct , 90 (921-6).
146. Pubmed Abramochkin D. et al. Effects of new class III antiarrhythmic drug niferidil on electrical activity in murine ventricular myocardium and their ionic mechanisms. Naunyn Schmiedebergs Arch. Pharmacol., 2015 Oct , 388 (1105-12).
145. Pubmed Kollár S. et al. Impact of aging on calcium influx and potassium channel characteristics of T lymphocytes. Oncotarget, 2015 May 30 , 6 (13750-6).
144. Pubmed Myles R. et al. Decreased inward rectifying K+ current and increased ryanodine receptor sensitivity synergistically contribute to sustained focal arrhythmia in the intact rabbit heart. J. Physiol. (Lond.), 2015 Mar 15 , 593 (1479-93).
143. Pubmed Deng Y. et al. Magnolol and honokiol regulate the calcium-activated potassium channels signaling pathway in Enterotoxigenic Escherichia coli-induced diarrhea mice. Eur. J. Pharmacol., 2015 Mar 11 , ().
142. Pubmed Ma S. et al. H2S targets the Cys320/Cys529 motif in Kv4.2 to inhibit the Ito potassium channels in cardiomyocytes and regularizes fatal arrhythmia in myocardial infarction. Antioxid. Redox Signal., 2015 Mar 10 , ().
141. Pubmed Dominguez Rieg J. et al. P2Y₂ receptor activation decreases blood pressure via intermediate conductance potassium channels and connexin 37. Acta Physiol (Oxf), 2015 Mar , 213 (628-41).
140. Pubmed Chang S. et al. N-Terminally extended analogues of the K⁺ channel toxin from Stichodactyla helianthus as potent and selective blockers of the voltage-gated potassium channel Kv1.3. FEBS J., 2015 Jun , 282 (2247-59).
139. Pubmed Li X. et al. Valsartan Upregulates Kir2.1 in Rats Suffering from Myocardial Infarction via Casein Kinase 2. Cardiovasc Drugs Ther, 2015 Jun , 29 (209-18).
138. Pubmed Henríquez C. et al. The calcium-activated potassium channel KCa3.1 plays a central role in the chemotactic response of mammalian neutrophils. Acta Physiol (Oxf), 2015 Jul 3 , ().
137. Pubmed Friebel K. et al. Functional role of the KCa3.1 potassium channel in synovial fibroblasts from rheumatoid arthritis patients. J. Cell. Physiol., 2015 Jul , 230 (1677-88).
136. Pubmed Cordeiro J. et al. Regional variation of the inwardly rectifying potassium current in the canine heart and the contributions to differences in action potential repolarization. J. Mol. Cell. Cardiol., 2015 Jul , 84 (52-60).
135. Pubmed Mishra R. et al. Inhibition of Myogenic Tone in Rat Cremaster and Cerebral Arteries by SKA-31, an Activator of Endothelial KCa2.3 and KCa3.1 Channels. J. Cardiovasc. Pharmacol., 2015 Jul , 66 (118-27).
134. Pubmed Chen Y. et al. Blood-brain barrier KCa3.1 channels: evidence for a role in brain Na uptake and edema in ischemic stroke. Stroke, 2015 Jan , 46 (237-44).
133. Pubmed Gillet L. et al. Cardiac-specific ablation of synapse-associated protein SAP97 in mice decreases potassium currents but not sodium current. Heart Rhythm, 2015 Jan , 12 (181-92).
132. Pubmed Váczi K. et al. 9-Anthracene carboxylic acid is more suitable than DIDS for characterization of calcium-activated chloride current during canine ventricular action potential. Naunyn Schmiedebergs Arch. Pharmacol., 2015 Jan , 388 (87-100).
131. Pubmed Huang C. et al. KCa3.1: a new player in progressive kidney disease. Curr. Opin. Nephrol. Hypertens., 2015 Jan , 24 (61-6).
130. Pubmed Qi X. et al. Fibroblast inward-rectifier potassium current upregulation in profibrillatory atrial remodeling. Circ. Res., 2015 Feb 27 , 116 (836-45).
129. Pubmed Long V. et al. Heart failure duration progressively modulates the arrhythmia substrate through structural and electrical remodeling. Life Sci., 2015 Feb 15 , 123 (61-71).
128. Pubmed Oliván-Viguera A. et al. A novel pan-negative-gating modulator of KCa2/3 channels, fluoro-di-benzoate, RA-2, inhibits endothelium-derived hyperpolarization-type relaxation in coronary artery and produces bradycardia in vivo. Mol. Pharmacol., 2015 Feb , 87 (338-48).
127. Pubmed Gasparoli L. et al. New pyrimido-indole compound CD-160130 preferentially inhibits the KV11.1B isoform and produces antileukemic effects without cardiotoxicity. Mol. Pharmacol., 2015 Feb , 87 (183-96).
126. Pubmed Littlechild R. et al. Inhibition of KCa3.1 by depolarisation and 2-aminoethoxydiphenyl borate (2-APB) during Ca²⁺ release activated Ca²⁺ (CRAC) entry in human erythroleukemia (HEL) cells: Implications for the interpretation of 2-APB inhibition of CRAC entry. Cell Calcium, 2015 Feb , 57 (76-88).
125. Pubmed Turner R. et al. Neuronal expression of the intermediate conductance calcium-activated potassium channel KCa3.1 in the mammalian central nervous system. Pflugers Arch., 2015 Feb , 467 (311-28).
124. Pubmed Choi J. et al. Lyso-globotriaosylceramide downregulates KCa3.1 channel expression to inhibit collagen synthesis in fibroblasts. Biochem. Biophys. Res. Commun., 2015 Dec 25 , 468 (883-8).
123. Pubmed Alonso H. et al. Thyroid stimulating hormone directly modulates cardiac electrical activity. J. Mol. Cell. Cardiol., 2015 Dec , 89 (280-6).
122. Pubmed Zhou X. et al. Nucleoside diphosphate kinase B-activated intermediate conductance potassium channels are critical for neointima formation in mouse carotid arteries. Arterioscler. Thromb. Vasc. Biol., 2015 Aug , 35 (1852-61).
121. Pubmed Zúñiga-García V. et al. Differential Expression of Ion Channels and Transporters During Hepatocellular Carcinoma Development. Dig. Dis. Sci., 2015 Apr 5 , ().
120. Pubmed Huang Y. et al. [Combined transgenic inhibition of CaMKII and Ik1 on cardiac remodeling]. Sheng Li Xue Bao, 2015 Apr 25 , 67 (201-6).
119. Pubmed Freise C. et al. K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells. Liver Int., 2015 Apr , 35 (1244-52).
118. Pubmed Waeckel L. et al. Preserved regulation of renal perfusion pressure by small and intermediate conductance KCa channels in hypertensive mice with or without renal failure. Pflugers Arch., 2015 Apr , 467 (817-31).
117. Pubmed Sun J. et al. Microelectrode array measurement of potassium ion channel remodeling on the field action potential duration in rapid atrial pacing rabbits model. Int J Clin Exp Med, 2015 , 8 (249-56).
116. Pubmed Meijer van Putten R. et al. Ion channelopathies in human induced pluripotent stem cell derived cardiomyocytes: a dynamic clamp study with virtual IK1. Front Physiol, 2015 , 6 (7).
115. Pubmed Lin H. et al. Lentiviral shRNA against KCa3.1 inhibits allergic response in allergic rhinitis and suppresses mast cell activity via PI3K/AKT signaling pathway. Sci Rep, 2015 , 5 (13127).
114. Pubmed Duffy S. et al. Orai/CRACM1 and KCa3.1 ion channels interact in the human lung mast cell plasma membrane. Cell Commun. Signal, 2015 , 13 (32).
113. Pubmed Arthur G. et al. KCa3.1 K+ Channel Expression and Function in Human Bronchial Epithelial Cells. PLoS ONE, 2015 , 10 (e0145259).
112. Pubmed Nakamura K. et al. Proinflammatory Cytokines and Potassium Channels in the Kidney. Mediators Inflamm., 2015 , 2015 (362768).
111. Pubmed Penna A. et al. KCa3.1-Dependent Hyperpolarization Enhances Intracellular Ca2+ Signaling Induced by fMLF in Differentiated U937 Cells. PLoS ONE, 2015 , 10 (e0139243).
110. Pubmed Saito Y. et al. Enhancement of Spontaneous Activity by HCN4 Overexpression in Mouse Embryonic Stem Cell-Derived Cardiomyocytes - A Possible Biological Pacemaker. PLoS ONE, 2015 , 10 (e0138193).
109. Pubmed Ju C. et al. Blockade of KCa3.1 Attenuates Left Ventricular Remodeling after Experimental Myocardial Infarction. Cell. Physiol. Biochem., 2015 , 36 (1305-15).
108. Pubmed Cahalan S. et al. Piezo1 links mechanical forces to red blood cell volume. Elife, 2015 , 4 ().
107. Pubmed Rabjerg M. et al. High expression of KCa3.1 in patients with clear cell renal carcinoma predicts high metastatic risk and poor survival. PLoS ONE, 2015 , 10 (e0122992).
106. Pubmed Kudryashova N. et al. Conditions for Waveblock Due to Anisotropy in a Model of Human Ventricular Tissue. PLoS ONE, 2015 , 10 (e0141832).
105. Pubmed Thireau J. et al. ACE Inhibitor Delapril Prevents Ca(2+)-Dependent Blunting of IK1 and Ventricular Arrhythmia in Ischemic Heart Disease. Curr. Mol. Med., 2015 , 15 (642-51).
104. Pubmed Zhang Y. et al. Effects of the venom of the spider Ornithoctonus hainana on neonatal rat ventricular myocytes cellular and ionic electrophysiology. Toxicon, 2014 Sep , 87 (104-12).
103. Pubmed Asakura K. et al. EAD and DAD mechanisms analyzed by developing a new human ventricular cell model. Prog. Biophys. Mol. Biol., 2014 Sep , 116 (11-24).
102. Pubmed Ongerth T. et al. Targeting of microglial KCa3.1 channels by TRAM-34 exacerbates hippocampal neurodegeneration and does not affect ictogenesis and epileptogenesis in chronic temporal lobe epilepsy models. Eur. J. Pharmacol., 2014 Oct 5 , 740 (72-80).
101. Pubmed Xu B. et al. Alternations of cardiac IK1 and Ito from FKBP12.6 transgenic mouse heart and potential impact of cardiac hypertrophy. Int. J. Cardiol., 2014 Oct 20 , 176 (1017-20).
100. Pubmed Wong R. et al. PKA reduces the rat and human KCa3.1 current, CaM binding, and Ca2+ signaling, which requires Ser332/334 in the CaM-binding C terminus. J. Neurosci., 2014 Oct 1 , 34 (13371-83).
99. Pubmed Kharche S. et al. Effects of human atrial ionic remodelling by β-blocker therapy on mechanisms of atrial fibrillation: a computer simulation. Europace, 2014 Oct , 16 (1524-33).
98. Pubmed Huang C. et al. Role of the potassium channel KCa3.1 in diabetic nephropathy. Clin. Sci., 2014 Oct , 127 (423-33).
97. Pubmed Liu C. et al. Activation of IK1 channel by zacopride attenuates left ventricular remodeling in rats with myocardial infarction. J. Cardiovasc. Pharmacol., 2014 Oct , 64 (345-56).
96. Pubmed Wu B. et al. On the risk concerns of zacopride, a moderate IK1 channel agonist with cardiac protective action. J. Cardiovasc. Pharmacol., 2014 Oct , 64 (357-9).
95. Pubmed Curtis M. et al. Activation of IK1 by zacopride: amelioration of left ventricular remodeling, but at what risk? J. Cardiovasc. Pharmacol., 2014 Oct , 64 (343-4).
94. Pubmed Chen R. et al. Mechanisms and energetics of potassium channel block by local anesthetics and antifungal agents. Biochemistry, 2014 Nov 4 , 53 (6786-92).
93. Pubmed Haworth T. et al. Electrical excitability of the heart in a Chondrostei fish, the Siberian sturgeon (Acipenser baerii). Am. J. Physiol. Regul. Integr. Comp. Physiol., 2014 Nov 1 , 307 (R1157-66).
92. Pubmed Gómez R. et al. Structural basis of drugs that increase cardiac inward rectifier Kir2.1 currents. Cardiovasc. Res., 2014 Nov 1 , 104 (337-46).
91. Pubmed Maleckar M. et al. NS5806 partially restores action potential duration but fails to ameliorate calcium transient dysfunction in a computational model of canine heart failure. Europace, 2014 Nov , 16 Suppl 4 (iv46-iv55).
90. Pubmed Hansen L. et al. The role of T cell potassium channels, KV1.3 and KCa3.1, in the inflammatory cascade in ulcerative colitis. Dan Med J, 2014 Nov , 61 (B4946).
89. Pubmed Koch Hansen L. et al. Expression of T-cell KV1.3 potassium channel correlates with pro-inflammatory cytokines and disease activity in ulcerative colitis. J Crohns Colitis, 2014 Nov , 8 (1378-91).
88. Pubmed Abramochkin D. et al. Inhibition of the cardiac ATP-dependent potassium current by KB-R7943. Comp. Biochem. Physiol., Part A Mol. Integr. Physiol., 2014 May 17 , 175C (38-45).
87. Pubmed Shenton F. et al. Expression of transient receptor potential channels TRPC1 and TRPV4 in venoatrial endocardium of the rat heart. Neuroscience, 2014 May 16 , 267 (195-204).
86. Pubmed Ohya S. et al. Upregulation of KCa3.1 K(+) channel in mesenteric lymph node CD4(+) T lymphocytes from a mouse model of dextran sodium sulfate-induced inflammatory bowel disease. Am. J. Physiol. Gastrointest. Liver Physiol., 2014 May 15 , 306 (G873-85).
85. Pubmed Ye G. et al. Effects of Ca2+-activated potassium and inward rectifier potassium channel on the differentiation of endothelial progenitor cells from human peripheral blood. Mol. Biol. Rep., 2014 May , 41 (3413-23).
84. Pubmed Climent B. et al. Effects of obesity on vascular potassium channels. Curr Vasc Pharmacol, 2014 May , 12 (438-52).
83. Pubmed Panyi G. et al. Ion channels and anti-cancer immunity. Philos. Trans. R. Soc. Lond., B, Biol. Sci., 2014 Mar 19 , 369 (20130106).
82. Pubmed Colman M. et al. Evolution and pharmacological modulation of the arrhythmogenic wave dynamics in canine pulmonary vein model. Europace, 2014 Mar , 16 (416-23).
81. Pubmed Bae H. et al. The stimulating effects of nitric oxide on intermediate conductance Ca²⁺-activated K⁺ channels in human dermal fibroblasts through PKG pathways but not the PKA pathways. Chin J Physiol, 2014 Jun 30 , 57 (137-51).
80. Pubmed Coleman N. et al. New Positive KCa Channel Gating Modulators with Selectivity for KCa3.1. Mol. Pharmacol., 2014 Jun 23 , ().
79. Pubmed Turner K. et al. A proinvasive role for the Ca(2+) -activated K(+) channel KCa3.1 in malignant glioma. Glia, 2014 Jun , 62 (971-81).
78. Pubmed Li H. et al. GATA-4 induces changes in electrophysiological properties of rat mesenchymal stem cells. Biochim. Biophys. Acta, 2014 Jun , 1840 (2060-9).
77. Pubmed Catalán M. et al. Ca(2+)-dependent K(+) channels in exocrine salivary glands. Cell Calcium, 2014 Jun , 55 (362-8).
76. Pubmed Wang L. et al. [Relation of intermediate-conductance Ca(2+)-activated K(+) channels with ability of proliferation, migration, invasion and IgE secretion of multiple myeloma cells]. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 2014 Jun , 22 (742-6).
75. Pubmed Kucherenko Y. et al. Niflumic Acid Affects Store-Operated Ca(2+)-Permeable (SOC) and Ca (2+)-Dependent K (+) and Cl (-) Ion Channels and Induces Apoptosis in K562 Cells. J. Membr. Biol., 2014 Jul , 247 (627-38).
74. Pubmed Freise C. et al. Inhibition of vascular calcification by block of intermediate conductance calcium-activated potassium channels with TRAM-34. Pharmacol. Res., 2014 Jul , 85 (6-14).
73. Pubmed Yu Z. et al. Targeted inhibition of KCa3.1 attenuates TGF-β-induced reactive astrogliosis through the Smad2/3 signaling pathway. J. Neurochem., 2014 Jul , 130 (41-9).
72. Pubmed Orban C. et al. Different calcium influx characteristics upon Kv1.3 and IKCa1 potassium channel inhibition in T helper subsets. Cytometry A, 2014 Jul , 85 (636-41).
71. Pubmed Zhang Q. et al. [Effects of telmisartan on IKCa1 potassium channel after T-lymphocyte activation and proliferation in peripheral blood of hypertensive patients in Xinjiang Kazakh]. Zhonghua Yi Xue Za Zhi, 2014 Jan 21 , 94 (182-6).
70. Pubmed Liu Y. et al. Protective effect of piperine on electrophysiology abnormalities of left atrial myocytes induced by hydrogen peroxide in rabbits. Life Sci., 2014 Jan 17 , 94 (99-105).
69. Pubmed Turner R. et al. T-type channels buddy up. Pflugers Arch., 2014 Jan 11 , ().
68. Pubmed Qu Y. et al. Remodeling of ion channel expression may contribute to electrophysiological consequences caused by methamphetamine in vitro and in vivo. Biochem. Biophys. Res. Commun., 2014 Jan 10 , 443 (441-6).
67. Pubmed Qian X. et al. Positive feedback regulation of agonist-stimulated endothelial Ca2+ dynamics by KCa3.1 channels in mouse mesenteric arteries. Arterioscler. Thromb. Vasc. Biol., 2014 Jan , 34 (127-35).
66. Pubmed Choi S. et al. Globotriaosylceramide induces lysosomal degradation of endothelial KCa3.1 in fabry disease. Arterioscler. Thromb. Vasc. Biol., 2014 Jan , 34 (81-9).
65. Pubmed Sun H. et al. Ionic mechanism underlying distinctive excitability in atrium and ventricle of the heart. Sheng Li Xue Bao, 2014 Feb 25 , 66 (85-95).
64. Pubmed Zhang J. et al. Overexpression of myocardin induces partial transdifferentiation of human-induced pluripotent stem cell-derived mesenchymal stem cells into cardiomyocytes. Physiol Rep, 2014 Feb 1 , 2 (e00237).
63. Pubmed Wang Y. et al. [Ca(2+)-activated K(+) channel switching in smooth muscle participates in atherosclerosis development in diabetic rats]. Nan Fang Yi Ke Da Xue Xue Bao, 2014 Feb , 34 (188-92).
62. Pubmed Garneau L. et al. Aromatic-aromatic interactions between residues in KCa3.1 pore helix and S5 transmembrane segment control the channel gating process. J. Gen. Physiol., 2014 Feb , 143 (289-307).
61. Pubmed Huang C. et al. Inhibition of KCa3.1 suppresses TGF-β1 induced MCP-1 expression in human proximal tubular cells through Smad3, p38 and ERK1/2 signaling pathways. Int. J. Biochem. Cell Biol., 2014 Feb , 47 (1-10).
60. Pubmed Huang C. et al. KCa3.1 mediates activation of fibroblasts in diabetic renal interstitial fibrosis. Nephrol. Dial. Transplant., 2014 Feb , 29 (313-24).
59. Pubmed Zhao L. et al. Advanced glycation end products impair K(Ca)3.1- and K(Ca)2.3-mediated vasodilatation via oxidative stress in rat mesenteric arteries. Pflugers Arch., 2014 Feb , 466 (307-17).
58. Pubmed Shao Z. et al. Intermediate-conductance calcium-activated potassium channel KCa3.1 and chloride channel modulate chemokine ligand (CCL19/CCL21)-induced migration of dendritic cells. Transl Res, 2014 Dec 20 , ().
57. Pubmed Lin H. et al. Ca2+ -activated K+ channel-3.1 blocker TRAM-34 alleviates murine allergic rhinitis. Int. Immunopharmacol., 2014 Dec , 23 (642-8).
56. Pubmed Xynogalos P. et al. Class III antiarrhythmic drug dronedarone inhibits cardiac inwardly rectifying Kir2.1 channels through binding at residue E224. Naunyn Schmiedebergs Arch. Pharmacol., 2014 Dec , 387 (1153-61).
55. Pubmed Kang H. et al. Kcnn4 is a regulator of macrophage multinucleation in bone homeostasis and inflammatory disease. Cell Rep, 2014 Aug 21 , 8 (1210-24).
54. Pubmed Wang Y. et al. [Electrophysiological study on the antiarrhythmic mechanism of ampelopsin in rats]. Zhonghua Xin Xue Guan Bing Za Zhi, 2014 Aug , 42 (675-9).
53. Pubmed Bébarová M. et al. Dual effect of ethanol on inward rectifier potassium current IK1 in rat ventricular myocytes. J. Physiol. Pharmacol., 2014 Aug , 65 (497-509).
52. Pubmed Grössinger E. et al. Targeting proliferation of chronic lymphocytic leukemia (CLL) cells through KCa3.1 blockade. Leukemia, 2014 Apr , 28 (954-8).
51. Pubmed Bertuccio C. et al. Anterograde trafficking of KCa3.1 in polarized epithelia is Rab1- and Rab8-dependent and recycling endosome-independent. PLoS ONE, 2014 , 9 (e92013).
50. Pubmed Roach K. et al. Increased constitutive αSMA and Smad2/3 expression in idiopathic pulmonary fibrosis myofibroblasts is KCa3.1-dependent. Respir. Res., 2014 , 15 (155).
49. Pubmed Gu J. et al. Pioglitazone improves potassium channel remodeling induced by angiotensin II in atrial myocytes. Med Sci Monit Basic Res, 2014 , 20 (153-60).
48. Pubmed Ferreira R. et al. IL-4 type 1 receptor signaling up-regulates KCNN4 expression, and increases the KCa3.1 current and its contribution to migration of alternative-activated microglia. Front Cell Neurosci, 2014 , 8 (183).
47. Pubmed Folyovich A. et al. Kv1.3 lymphocyte potassium channel inhibition as a potential novel therapeutic target in acute ischemic stroke. CNS Neurol Disord Drug Targets, 2014 , 13 (801-6).
46. Pubmed Odagiri F. et al. Effects of candesartan on electrical remodeling in the hearts of inherited dilated cardiomyopathy model mice. PLoS ONE, 2014 , 9 (e101838).
45. Pubmed Xu H. et al. Tumor-associated macrophage-derived IL-6 and IL-8 enhance invasive activity of LoVo cells induced by PRL-3 in a KCNN4 channel-dependent manner. BMC Cancer, 2014 , 14 (330).
44. Pubmed Wandall-Frostholm C. et al. Pulmonary hypertension in wild type mice and animals with genetic deficit in KCa2.3 and KCa3.1 channels. PLoS ONE, 2014 , 9 (e97687).
43. Pubmed Yu C. et al. Apamin does not inhibit human cardiac Na+ current, L-type Ca2+ current or other major K+ currents. PLoS ONE, 2014 , 9 (e96691).
42. Pubmed Tong W. et al. Computational modeling reveals key contributions of KCNQ and hERG currents to the malleability of uterine action potentials underpinning labor. PLoS ONE, 2014 , 9 (e114034).
41. Pubmed Climent B. et al. Upregulation of SK3 and IK1 channels contributes to the enhanced endothelial calcium signaling and the preserved coronary relaxation in obese Zucker rats. PLoS ONE, 2014 , 9 (e109432).
40. Pubmed Gole H. et al. Upregulation of intermediate-conductance Ca2+-activated K+ channels (KCNN4) in porcine coronary smooth muscle requires NADPH oxidase 5 (NOX5). PLoS ONE, 2014 , 9 (e105337).
39. Pubmed O'Hara B. et al. Multiple mineralocorticoid response elements localized in different introns regulate intermediate conductance K+ (Kcnn4) channel expression in the rat distal colon. PLoS ONE, 2014 , 9 (e98695).
38. Pubmed Huang C. et al. High glucose induces CCL20 in proximal tubular cells via activation of the KCa3.1 channel. PLoS ONE, 2014 , 9 (e95173).
37. Pubmed Simma N. et al. NMDA-receptor antagonists block B-cell function but foster IL-10 production in BCR/CD40-activated B cells. Cell Commun. Signal, 2014 , 12 (75).
36. Pubmed Yap F. et al. Ovariectomy-induced reductions in endothelial SK3 channel activity and endothelium-dependent vasorelaxation in murine mesenteric arteries. PLoS ONE, 2014 , 9 (e104686).
35. Pubmed Jenkins D. et al. Development of a QPatch automated electrophysiology assay for identifying KCa3.1 inhibitors and activators. Assay Drug Dev Technol, 2013 Nov-Dec , 11 (551-60).
34. Pubmed Colman M. et al. Pro-arrhythmogenic effects of atrial fibrillation-induced electrical remodelling: insights from the three-dimensional virtual human atria. J. Physiol. (Lond.), 2013 Sep 1 , 591 (4249-72).
33. Pubmed Abramochkin D. et al. Inhibition of the cardiac inward rectifier potassium currents by KB-R7943. Comp. Biochem. Physiol. C Toxicol. Pharmacol., 2013 Sep , 158 (181-6).
32. Pubmed Zhang L. et al. Zacopride selectively activates the Kir2.1 channel via a PKA signaling pathway in rat cardiomyocytes. Sci China Life Sci, 2013 Sep , 56 (788-96).
31. Pubmed van der Heyden M. et al. Inhibition of cardiac inward rectifier currents by cationic amphiphilic drugs. Curr. Mol. Med., 2013 Sep , 13 (1284-98).
30. Pubmed Radtke J. et al. Activation of KCa3.1 by SKA-31 induces arteriolar dilatation and lowers blood pressure in normo- and hypertensive connexin40-deficient mice. Br. J. Pharmacol., 2013 Sep , 170 (293-303).
29. Pubmed Chen R. et al. Molecular dynamics simulations of scorpion toxin recognition by the Ca(2+)-activated potassium channel KCa3.1. Biophys. J., 2013 Oct 15 , 105 (1829-37).
28. Pubmed Song Y. et al. Regulatory functions of docosahexaenoic acid on ion channels in rat ventricular myocytes. Eur Rev Med Pharmacol Sci, 2013 Oct , 17 (2632-8).
27. Pubmed Chinnathambi V. et al. Prenatal testosterone induces sex-specific dysfunction in endothelium-dependent relaxation pathways in adult male and female rats. Biol. Reprod., 2013 Oct , 89 (97).
26. Pubmed Stoneking C. et al. Mg(2+) modulation of the single-channel properties of KCa3.1 in human erythroleukemia cells. Pflugers Arch., 2013 Nov 6 , ().
25. Pubmed Soltan Mohammadi N. et al. Identification and characterization of the channel-forming protein in the cell wall of Corynebacterium amycolatum. Biochim. Biophys. Acta, 2013 Nov , 1828 (2574-82).
24. Pubmed Horváth B. et al. Dynamics of the late Na(+) current during cardiac action potential and its contribution to afterdepolarizations. J. Mol. Cell. Cardiol., 2013 Nov , 64 (59-68).
23. Pubmed Nagy N. et al. [Ca²⁺] i-induced augmentation of the inward rectifier potassium current (IK1) in canine and human ventricular myocardium. Pflugers Arch., 2013 Nov , 465 (1621-35).
22. Pubmed Yu Z. et al. Up-regulation of KCa3.1 promotes human airway smooth muscle cell phenotypic modulation. Pharmacol. Res., 2013 Nov , 77 (30-8).
21. Pubmed Fagerberg S. et al. P2X receptor-dependent erythrocyte damage by α-hemolysin from Escherichia coli triggers phagocytosis by THP-1 cells. Toxins (Basel), 2013 Mar , 5 (472-87).
20. Pubmed Su X. et al. Role of KCa3.1 channels in proliferation and migration of vascular smooth muscle cells by diabetic rat serum. Chin J Physiol, 2013 Jun 30 , 56 (155-62).
19. Pubmed Wei Y. et al. Enhancement of polydatin on inward rectifier potassium channel current in rat ventricular myocytes. Sheng Li Xue Bao, 2013 Jun 25 , 65 (285-92).
18. Pubmed Kistamás K. et al. Effects of pioglitazone on cardiac ion currents and action potential morphology in canine ventricular myocytes. Eur. J. Pharmacol., 2013 Jun 15 , 710 (10-9).
17. Pubmed Shmukler B. et al. N-ethylmaleimide activates a Cl(-)-independent component of K(+) flux in mouse erythrocytes. Blood Cells Mol. Dis., 2013 Jun , 51 (9-16).
16. Pubmed Morales P. et al. Contribution of the KCa3.1 channel-calmodulin interactions to the regulation of the KCa3.1 gating process. J. Gen. Physiol., 2013 Jul , 142 (37-60).
15. Pubmed Cordeiro J. et al. Identification and characterization of a transient outward K+ current in human induced pluripotent stem cell-derived cardiomyocytes. J. Mol. Cell. Cardiol., 2013 Jul , 60 (36-46).
14. Pubmed Yang X. et al. Inhibitory effects of blockage of intermediate conductance Ca(2+)-activated K (+) channels on proliferation of hepatocellular carcinoma cells. J. Huazhong Univ. Sci. Technol. Med. Sci., 2013 Feb , 33 (86-9).
13. Pubmed Kahlfuß S. et al. Immunosuppression by NMDA-Receptor Antagonists is Mediated Through Inhibition of Kv1.3 and KCa3.1 Channels in T cells. Mol. Cell. Biol., 2013 Dec 16 , ().
12. Pubmed Chimote A. et al. Selective Inhibition of KCa3.1 Channels Mediates Adenosine Regulation of the Motility of Human T Cells. J. Immunol., 2013 Dec 15 , 191 (6273-80).
11. Pubmed Sukumaran S. et al. TRPV4 channel activation leads to endothelium-dependent relaxation mediated by nitric oxide and endothelium-derived hyperpolarizing factor in rat pulmonary artery. Pharmacol. Res., 2013 Dec , 78 (18-27).
10. Pubmed Zhang Q. et al. [Voltage-dependent potassium channel and calcium-activated potassium channel current changes of peripheral blood T-lymphocytes from hypertensive patients in Xinjiang Kazakh]. Zhonghua Xin Xue Guan Bing Za Zhi, 2013 Dec , 41 (1020-4).
9. Pubmed Huang C. et al. Blockade of KCa3.1 ameliorates renal fibrosis through the TGF-β1/Smad pathway in diabetic mice. Diabetes, 2013 Aug , 62 (2923-34).
8. Pubmed Huang W. et al. Antiarrhythmic effects and ionic mechanisms of allicin on myocardial injury of diabetic rats induced by streptozotocin. Naunyn Schmiedebergs Arch. Pharmacol., 2013 Aug , 386 (697-704).
7. Pubmed Voigt N. et al. Impaired Na⁺-dependent regulation of acetylcholine-activated inward-rectifier K⁺ current modulates action potential rate dependence in patients with chronic atrial fibrillation. J. Mol. Cell. Cardiol., 2013 Aug , 61 (142-52).
6. Pubmed Hejl J. et al. P2X receptor stimulation amplifies complement-induced haemolysis. Pflugers Arch., 2013 Apr , 465 (529-41).
5. Pubmed Roach K. et al. The K(+) Channel KCa3.1 as a Novel Target for Idiopathic Pulmonary Fibrosis. PLoS ONE, 2013 , 8 (e85244).
4. Pubmed Ferreira R. et al. Selective activation of KCa3.1 and CRAC channels by P2Y2 receptors promotes Ca(2+) signaling, store refilling and migration of rat microglial cells. PLoS ONE, 2013 , 8 (e62345).
3. Pubmed Lai W. et al. KCNN4 channels participate in the EMT induced by PRL-3 in colorectal cancer. Med. Oncol., 2013 , 30 (566).
2. Pubmed Chen Y. et al. The Ca²⁺-activated K⁺ channel KCa3.1 as a potential new target for the prevention of allograft vasculopathy. PLoS ONE, 2013 , 8 (e81006).
1. Pubmed Koshy S. et al. Blocking KCa3.1 channels increases tumor cell killing by a subpopulation of human natural killer lymphocytes. PLoS ONE, 2013 , 8 (e76740).